Additional file 1 of A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients

Additional file 1: Fig. S1. A detailed schematic of the study. Fig. S2. The mutation landscape in the two cohorts. A. The mutation landscape and clinical characteristics in patients with hematuria. B. The mutation landscape and clinical characteristics in patients with NMIBC. Table S1. Patients’ characteristics between OncoUrine positive and negative groups. Table S2. The predictive performance of OncoUrine during follow-up. Table S3. The gene list and primers of the OncoUrine panel. Table S4. The recurrence rate during follow-up in patients with false positive OncoUrine test results and with true negative results.